RUNX1 antibody

Principal name

RUNX1 antibody

Alternative names for RUNX1 antibody

Runt-related transcription factor, 1, AML1, AML-1, AMLCR1, Acute myeloid leukemia 1 protein, AML1-EVI-1, EVI-1, CBFA2, CBF-alpha-2, PEA2-alpha B, PEBP2-alpha B, PEBP2A2, Core-binding factor subunit alpha-2, Polyomavirus enhancer-binding protein 2 alpha B subunit, SL3-3 enhancer factor 1 alpha B subunit, SL3/AKV core-binding factor alpha B subunit

SwissProt ID

Q01196 (Human), Q03347 (Mouse), Q16284 (Human), Q63046 (Rat), Q6PF39 (Xenla)

Gene ID

861 (RUNX1), 12394 (Runx1), 50662

Available reactivities

Hu (Human), Ms (Mouse), Bov (Bovine), Can (Canine), Chk (Chicken), Rt (Rat), Ze (Zebrafish), African clawed frog, Por (Porcine)

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Flow Cytometry (F)

Background of RUNX1 antibody

RUNX1 belongs to the runt domain family of transcription factors and regulates target gene expression through forming a heterodimeric DNA-binding complex with CBFB. RUNX1 was first identified as a RUNX1-ETO fusion protein in acute myeloid leukaemia (AML) and is frequently mutated in AML and myelodysplastic syndrome due to chromosomal translocation. RUNX1-deficient mice fail to generate hematopoietic stem cells. RUNX1 regulates CD4 gene transcription during multiple stages of T cell development and represses the CD4 gene in CD4-CD8- (double negative) T cells. RUNX1 is also required for the differentiation of CD8+, Th17, and regulatory T cells. Impaired differentiation of megakaryocytes and decreased circulating platelet count was observed in the absence of RUNX1. These findings revealed that RUNX1 acts as a tumor suppressor for myeloid leukemia and is crucial for the development and terminal differentiation of several blood cell lineages.

General readings

Ghozi,M.C., et al., (1996) Proc. Natl. Acad. Sci. U.S.A. 93 (5), 1935-1940

  1. Quick-Filters:
  2. Cited (1)
  3. Highly Validated (2)

Items 21 to 40 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

RUNX1 pSer435 antibody

Western blot analysis of extracts from 293 cells (Lane 2), HeLa cells (Lane 3) and HepG2 cells (Lane 4), using AML1 (Phospho-Ser435) Antibody AP55801PU-N. The lane on the left is treated with antigen-specific peptide. Rabbit Aff - Purified Hu, Ms, Rt WB
0.1 mg / €340.00
  OriGene Technologies GmbH

RUNX1 pSer435 antibody

Western blot analysis of extracts from 293 cells (Lane 2), HeLa cells (Lane 3) and HepG2 cells (Lane 4), using AML1 (Phospho-Ser435) Antibody AP55801PU-N. The lane on the left is treated with antigen-specific peptide. Rabbit Aff - Purified Hu, Ms, Rt WB
50 µg / €270.00
  OriGene Technologies GmbH

RUNX1 pSer276 antibody

Western blot analysis of extracts from Jurkat cells, using AML1 (Phospho-Ser276) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
50 µg / €230.00
  Assay Biotech

RUNX1 pSer276 antibody

Western blot analysis of extracts from Jurkat cells, using AML1 (Phospho-Ser276) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
0.1 mg / €330.00
  Assay Biotech

RUNX1 pSer303 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using AML1 (Phospho-Ser303) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P, WB
50 µg / €230.00
  Assay Biotech

RUNX1 pSer303 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma, using AML1 (Phospho-Ser303) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P, WB
0.1 mg / €330.00
  Assay Biotech

RUNX1 pSer435 antibody

Western blot analysis of extracts from HepG2 cells treated with PMA 125ng/ml 30', using AML1 (Phospho-Ser435) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
50 µg / €230.00
  Assay Biotech

RUNX1 pSer435 antibody

Western blot analysis of extracts from HepG2 cells treated with PMA 125ng/ml 30', using AML1 (Phospho-Ser435) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
0.1 mg / €330.00
  Assay Biotech

RUNX1 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using AML1 (Ab-276) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P, WB
50 µg / €230.00
  Assay Biotech

RUNX1 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using AML1 (Ab-276) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P, WB
0.1 mg / €330.00
  Assay Biotech

RUNX1 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using AML1 (Ab-303) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, ICC/IF, P, WB
50 µg / €230.00
  Assay Biotech

RUNX1 antibody

Immunohistochemistry analysis of paraffin-embedded human lung carcinoma tissue, using AML1 (Ab-303) Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, ICC/IF, P, WB
0.1 mg / €330.00
  Assay Biotech

RUNX1 antibody

Western blot analysis of extracts from HepG2 cells, treated with PMA 125ng/ml 30', using AML1 (Ab-435) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
50 µg / €230.00
  Assay Biotech

RUNX1 antibody

Western blot analysis of extracts from HepG2 cells, treated with PMA 125ng/ml 30', using AML1 (Ab-435) Antibody. The lane on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, WB
0.1 mg / €330.00
  Assay Biotech

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

RUNX1 (transcript variant 2)

  Recombinant protein of human runt-related transcription factor 1 (RUNX1), transcript variant 2  
RUNX1 Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

Lysates

Catalog No.    

RUNX1 overexpression lysate

RUNX1 overexpression lysate  
0.1 mg / €495.00
  OriGene Technologies, Inc.

RUNX1 overexpression lysate

RUNX1 overexpression lysate  
0.1 mg / €495.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, RUNX1 (mGFP-tagged) - Human runt-related transcription factor 1 (RUNX1), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, RUNX1 (mGFP-tagged) - Human runt-related transcription factor 1 (RUNX1), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €1,082.00
  OriGene Technologies, Inc.

Lenti ORF particles, RUNX1 (mGFP-tagged)-Human runt-related transcription factor 1 (RUNX1), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, RUNX1 (mGFP-tagged)-Human runt-related transcription factor 1 (RUNX1), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €1,020.00
  OriGene Technologies, Inc.

Lenti ORF particles, RUNX1 (Myc-DDK tagged) - Human runt-related transcription factor 1 (RUNX1), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, RUNX1 (Myc-DDK tagged) - Human runt-related transcription factor 1 (RUNX1), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €969.00
  OriGene Technologies, Inc.

Items 21 to 40 of 51 total

per page
Page:
  1. 1
  2. 2
  3. 3
  • LinkedIn